↓ Skip to main content

MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cells

Overview of attention for article published in Journal of Translational Medicine, July 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
64 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cells
Published in
Journal of Translational Medicine, July 2013
DOI 10.1186/1479-5876-11-172
Pubmed ID
Authors

Bingxiang Xiao, Li Tan, Benfu He, Zhiliang Liu, Ruxiang Xu

Abstract

MicroRNAs have recently emerged as key regulators of cancers, miR-329 located on 14q32.31 is one of down-regulated miRNAs in glioma, but the function and molecular mechanisms of miR-329 in determining the malignant phenotype of human glioma are elusive. This study therefore was conducted to investigate the role of miR-329 in biological behaviors of human glioma LN18 and T98G cell lines and its molecular mechanisms.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 28%
Student > Master 6 24%
Researcher 5 20%
Student > Bachelor 2 8%
Professor 2 8%
Other 3 12%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 9 36%
Agricultural and Biological Sciences 8 32%
Medicine and Dentistry 3 12%
Neuroscience 2 8%
Computer Science 1 4%
Other 0 0%
Unknown 2 8%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 August 2013.
All research outputs
#15,274,954
of 22,715,151 outputs
Outputs from Journal of Translational Medicine
#2,233
of 3,973 outputs
Outputs of similar age
#106,149
of 172,132 outputs
Outputs of similar age from Journal of Translational Medicine
#19
of 27 outputs
Altmetric has tracked 22,715,151 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,973 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 172,132 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.